BioCryst Pharmaceuticals landed in the hidden value corner this week, its price down 23.1% over the last eight weeks. Its business ranks 98.6 out of 100 on quality, but its price ranks just 1.6 out of 100 on momentum. 1424 stocks were scored this week, and 359 share that same corner. Its quality rank of 98.6 sits well clear of the corner's own average of 74.8. It sits at 8.5 times forward earnings, against a map median of 14.9.
Want a channel or video like this for your brand or business? Contact studio@mixinumhq.com.
The narration is AI-written from this episode's data and read by a synthetic text-to-speech voice. Not financial advice. Every number here is public — check it.
#Shorts
More
The full map: https://thao.funnymoment.net/video/xbjju9u
Mixinum Financial Review: https://thao.funnymoment.net/mixinum
